Neuro C

国: オーストラリア

言語: 英語

ソース: Department of Health (Therapeutic Goods Administration)

即購入

公開評価報告書 公開評価報告書 (PAR)
22-11-2017

有効成分:

Ginkgo biloba, Quantity: 60 mg (Equivalent: Ginkgo biloba, Qty 3 g; Equivalent: Ginkgo flavonglycosides, Qty 14.7 mg; Equivalent: Ginkgolides and bilobalide, Qty 3.6 mg); d-alpha-tocopheryl acid succinate, Quantity: 8.26 mg; Bacopa monnieri, Quantity: 225 mg; soy phosphatidylserine-enriched soy lecithin powder, Quantity: 83.33 mg (Equivalent: soy phosphatidylserine, Qty 50 mg)

から入手可能:

Biomedica Nutraceuticals Pty Ltd

INN(国際名):

Bacopa monnieri,d-alpha-Tocopheryl acid succinate,Ginkgo biloba,soy phosphatidylserine-enriched soy lecithin powder

医薬品形態:

Capsule, hard

構図:

Excipient Ingredients: calcium hydrogen phosphate dihydrate; colloidal anhydrous silica; Rice bran; hypromellose; purified water; chlorophyllin-copper complex

投与経路:

Oral

適応症:

Antioxidant/Reduce free radicals formed in the body ; Helps reduce/decrease free radical damage to body cells ; Maintain/support general health and wellbeing ; Maintain/support healthy blood circulation ; Maintain/support blood circulation/flow to the peripheral areas of the body (legs, hands and feet) ; Maintain/support cognitive function/mental function ; Maintain/support memory/mental recall ; Maintain/support brain health ; Maintain/support nervous system health

製品概要:

Visual Identification: ;

認証ステータス:

Licence status A

承認日:

2017-07-25

ドキュメントの履歴を表示する